Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesComparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma
Current Medical Research and Opinion, 11/21/08
Yan DB et al. - The mean IOP in the first period when all patients were dosed in the evening was assessed 12 h after dosing at 09:00 and it was similar in the two treatment groups. In the a.m.-dosing crossover comparison, the 24-h post-dose IOP was significantly lower on travoprost compared to latanoprost.
| Previous Article | Next Article |
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis: beta-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Annals of Internal Medicine, 06/03/09
Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
The Journal of Pediatrics, 07/01/09
Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol
Anaesthesia, 06/10/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas
Cancer, 06/01/09
A population-based clinical trial of irinotecan and carboplatin
Journal of Oncology, 06/15/09
Rifampin and Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Preseptal Cellulitis
Ophthalmic Plastic and Reconstructive Surgery, 06/05/09
Article Search
Sponsor